217 related articles for article (PubMed ID: 2156991)
1. Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.
Lupica CR; Cass WA; Zahniser NR; Dunwiddie TV
J Pharmacol Exp Ther; 1990 Mar; 252(3):1134-41. PubMed ID: 2156991
[TBL] [Abstract][Full Text] [Related]
2. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
4. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
Jin S; Johansson B; Fredholm BB
J Pharmacol Exp Ther; 1993 Nov; 267(2):801-8. PubMed ID: 7902434
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes.
Bruns RF; Lu GH; Pugsley TA
Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
Casati C; Monopoli A; Dionisotti S; Zocchi C; Bonizzoni E; Ongini E
J Pharmacol Exp Ther; 1994 Mar; 268(3):1506-11. PubMed ID: 8138961
[TBL] [Abstract][Full Text] [Related]
7. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
[TBL] [Abstract][Full Text] [Related]
8. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
Levens N; Beil M; Jarvis M
J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
[TBL] [Abstract][Full Text] [Related]
9. mGluR-evoked augmentation of receptor-mediated cyclic AMP formation in neonatal and adult rat striatum.
Cartmell J; Schaffhauser H; Wichmann J; Mutel V
Br J Pharmacol; 1997 Aug; 121(7):1263-8. PubMed ID: 9257902
[TBL] [Abstract][Full Text] [Related]
10. An antagonistic interaction between A2B adenosine and D2 dopamine receptors modulates the function of rat carotid body chemoreceptor cells.
Conde SV; Gonzalez C; Batuca JR; Monteiro EC; Obeso A
J Neurochem; 2008 Dec; 107(5):1369-81. PubMed ID: 18823369
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
Gomes CA; Vaz SH; Ribeiro JA; Sebastião AM
Brain Res; 2006 Oct; 1113(1):129-36. PubMed ID: 16935271
[TBL] [Abstract][Full Text] [Related]
12. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
13. ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus.
Cunha RA; Constantino MD; Ribeiro JA
Br J Pharmacol; 1997 Dec; 122(7):1279-84. PubMed ID: 9421273
[TBL] [Abstract][Full Text] [Related]
14. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
15. Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska K; Zylewska A
Pol J Pharmacol; 1997; 49(5):317-22. PubMed ID: 9566030
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.
Ferre S; von Euler G; Johansson B; Fredholm BB; Fuxe K
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7238-41. PubMed ID: 1678519
[TBL] [Abstract][Full Text] [Related]
17. Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.
Conti A; Lozza G; Monopoli A
Pharmacol Res; 1997 Feb; 35(2):123-8. PubMed ID: 9175581
[TBL] [Abstract][Full Text] [Related]
18. Evidence for adenosine A2b receptors in the rat pineal gland.
Gharib A; Delton I; Lagarde M; Sarda N
Eur J Pharmacol; 1992 Apr; 225(4):359-60. PubMed ID: 1323481
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression.
Barraco RA; Martens KA; Parizon M; Normile HJ
Brain Res Bull; 1993; 31(3-4):397-404. PubMed ID: 8490738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
